2030 年骨坏死治疗市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00033413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

 

[研究报告] 骨坏死治疗市场规模预计将从2022年的6.3718亿美元增长到2030年的10.2192亿美元;预计2022年至2030年市场复合年增长率为6.08%。

 

分析师观点

骨坏死治疗市场分析解释了增长动力,例如由于道路交通事故增多以及患者长期使用类固醇导致骨坏死病例增加。此外,老年人口的激增和人们对骨骼健康的认识不断提高有利于骨坏死治疗市场的发展。然而,手术治疗的高成本和治疗药物相关的风险阻碍了市场的增长。在 2022-2030 年期间,骨科生物制剂和再生疗法的采用可能会成为骨坏死治疗市场的未来趋势。

骨坏死,又称缺血性坏死 (AVN),是一种因骨骼血流中断而引起的疼痛性骨病;病情会随着时间的推移而恶化,导致骨细胞死亡。骨坏死的风险因素包括骨折、髋关节脱臼、放射治疗和酗酒。

 

市场洞察

 

骨科损伤病例增加和老年人口增加推动骨坏死治疗市场增长

根据 Clevelandclinic.org 在 2021 年发布的统计数据,每年有 10,000-20,000 名美国人被诊断出患有 AVN,这种疾病影响所有年龄和性别的人。近 20% 的髋关节脱位患者会发展为缺血性坏死。由于致命事故造成的骨骼和关节损伤数量不断增加,全球骨坏死病例正在增加。虽然骨坏死更常见于髋关节,但它也会损害肱骨、膝盖和距骨的状况。根据 StatPearls 在 2023 年发表的一篇文章,AVN 导致美国 10% 的髋关节置换术,主要发生在 30-65 岁的人身上。髋关节或膝盖移位可能会切断腿部的血液供应。因此,腿部组织可能无法获得足够的血液(这种情况称为缺血)并可能死亡(这种情况称为坏死)。肘部或上臂骨折偶尔会阻碍血液流向前臂,造成类似的并发症。当骨骼的血液供应中断时,部分骨骼可能会坏死,导致骨坏死。根据 2022 年 1 月在 PubMed Central 上发表的一篇文章,进行了一项队列研究,其中包括 170,934 名重伤患者。该研究得出的结论是,78.0% 的患有创伤性髋关节脱位的重伤患者是在道路交通事故中受伤的,尤其是机动车事故(49.9%)。

老年人更容易发生骨坏死,因为他们更容易出现骨骼退化和骨折。在 2020 年 PubMed 发表的一篇文章中,一项研究评估了空心内固定对 73 例股骨颈骨折 (FNF) 患者的长期疗效,并确定了影响疗效的风险因素。研究结果显示,其中 7 例(即约 10%)出现股骨头坏死,4 例接受了髋关节置换术。根据世界卫生组织 (WHO) 的数据,到 2030 年,全球每 6 人中就有 1 人年龄在 60 岁或以上,预计 60 岁以上的人口将达到 14 亿。因此,老年人口的激增和人们对骨骼健康的日益认识有利于骨坏死治疗市场的发展。  

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

骨坏死治疗市场:

Osteonecrosis Treatment Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。


未来趋势

 

采用骨生物学和再生疗法将成为骨坏死治疗市场的未来趋势

骨再生医学是医学的一个分支,它利用生物学的优势来促进愈合、减轻疼痛、改善功能并创造有利于组织再生的环境,从而治愈骨科疾病。介入性骨生物学的作用基于骨再生的原理,正在彻底改变骨科医学领域。骨生物学来源于患者的组织,例如骨髓或血液。它们由刺激肌肉骨骼损伤愈合的信号分子或细胞组成。

干细胞疗法、富血小板血浆疗法、生长因子和组织工程等再生疗法正在临床试验中进行研究和评估,以优化治疗效果。在 2023 年 1 月 PubMed Central 发表的一篇文章中,进行了一项研究,以评估使用生物制剂治疗患有该病的 44 岁男性股骨头双侧 AVN 的效果。患者在右股骨头中接受了骨​​髓抽吸浓缩物 (BMAC),在左股骨头中接受了成人自体活培养成骨细胞,之后,他被要求进行数年的随访。该研究得出结论,与未分化的 BMAC 鸡尾酒相比,使用分化成骨细胞的生物疗法是 AVN 股骨头的可行选择。

骨坏死治疗市场的主要参与者正在致力于创新疗法的研发以及产品的推出。2021 年 2 月,Additive Orthopedics, LLC 获得了美国食品药品监督管理局 (FDA) 对其首款患者专用距骨间隔器的批准,这也是世界上第一个人道主义用途的植入物。同样,全球领先的医疗器械公司 Arthrex 现在提供用于治疗自发性膝关节骨坏死 (SONK) 的骨内生物成形术 (IOBP) 技术。该技术包括对病变进行核心减压,然后直接应用浓缩骨髓抽吸物,该抽吸物是使用 Angel 浓缩富血小板血浆 (cPRP) 系统制备的。

 

报告细分和范围

“骨坏死治疗市场”根据治疗类型、最终用户和地理位置进行细分。根据产品类型,市场分为药物和手术。就最终用户而言,市场分为医院、专科诊所、门诊手术中心和其他。根据地理位置,骨坏死治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)

 

治疗类型 – 基于见解

根据治疗类型,骨坏死治疗市场分为药物和手术。药物领域在 2020-2030 年占据最高市场份额。然而,预计手术领域的复合年增长率最高,为 7.63%。

 

基于最终用户的洞察

就最终用户而言,骨坏死治疗市场分为医院、专科诊所、门诊手术中心和其他。预计医院部门将在 2022-2030 年期间创下市场最高复合年增长率。骨坏死治疗涉及需要特殊医疗护理的复杂手术,包括诊断、治疗和持续监测。医院在为骨坏死患者提供完整的医疗保健服务方面发挥着重要作用。根据疾病的阶段和严重程度,它们为骨坏死提供多种治疗选择。这些治疗可能包括保守技术,例如疼痛管理、物理治疗和生活方式改变。此外,在严重情况下,可以进行关节保留手术或关节置换手术等外科治疗。

 

 

骨坏死治疗市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响骨坏死治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的骨坏死治疗市场细分和地理位置。

Osteonecrosis Treatment Market
  • 获取骨坏死治疗市场的区域特定数据

骨坏死治疗市场报告范围

报告属性细节
2022 年市场规模6.3718亿美元
2030 年市场规模10.2192亿美元
全球复合年增长率(2022 - 2030 年)6.08%
史料2020-2022
预测期2022-2030
涵盖的领域按治疗类型
  • 药物和手术
按最终用户
  • 医院
  • 专科诊所
  • 门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 诺华公司
  • 梯瓦制药工业有限公司
  • 齐默邦美
  • 辉瑞公司
  • 史赛克
  • Exactech 公司
  • 默克公司
  • 雷迪博士

市场参与者密度:了解其对商业动态的影响

骨坏死治疗市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在骨坏死治疗市场运营的主要公司有:

  1. 诺华公司
  2. 梯瓦制药工业有限公司
  3. 齐默邦美
  4. 辉瑞公司
  5. 史赛克

免责声明上面列出的公司没有按照任何特定顺序排列。


Osteonecrosis Treatment Market

 

  • 了解骨坏死治疗市场顶级关键参与者概述

 

区域分析

北美骨坏死治疗市场预计将在预测期内大幅增长,原因是先进治疗方案的普及和采用率高,以及该地区主要制造商的集中度高。尤其是美国,骨坏死治疗的采用率很高。

报告介绍了全球骨坏死治疗市场的重要参与者。其中包括诺华公司、梯瓦制药工业有限公司、Zimmer Biomet、辉瑞公司、史赛克、Exactech、默克公司、雷迪博士实验室有限公司、Viatris Inc 和 Horizo​​n Therapeutics plc。这些领先企业专注于扩大和多样化其市场影响力和客户群,从而挖掘骨坏死治疗市场中的商机。

主要市场参与者的一些关键发展如下:

  • 2022 年 5 月,Regrow Biosciences 获得了美国食品药品监督管理局 (FDA) 和欧洲药品管理局 (EMA) 颁发的 OSSGROW 孤儿药资格 (ODD)。该药物适用于患有骨坏死的患者。
  • 2021 年 4 月,ECI Pharmaceuticals LLC 与 AiPing Pharmaceuticals, Inc. 签署了独家分销协议。该协议授权 AiPing 负责美国布洛芬 400 毫克、600 毫克、800 毫克片剂和叶酸 1 毫克片剂的销售、营销和分销。
  • 2021 年 2 月,Additive Orthopaedics 获得 FDA 批准,可在美国生产全距骨置换植入物,该植入物设计为距骨间隔器的人道主义用途设备,用于针对患者的距骨缺血性坏死治疗。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is osteonecrosis and what treatments are available in the market?

Osteonecrosis, also known as avascular necrosis (AVN), is a painful bone disease caused due to the disruption of blood flow to bones; the condition worsens with time and results in the death of bone cells. The risk factors for osteonecrosis include broken bones, dislocated hips, radiation therapy, and alcohol abuse. Treatments such as drugs including NSAIDs, blood thinners, cholesterol lowering drugs and surgical procedures such as total joint replacement/ total hip arthroplasty (THA), core decompression surgery, bone graft, osteotomy is available.

Which region is expected to witness significant demand for osteonecrosis treatment market in the coming years?

Global osteonecrosis treatment market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The osteonecrosis treatment market in North America is expected to grow at a significant rate during the forecast period owing to factors such as the high availability and adoption of advanced treatment options, and the concentration of key manufacturers in the region. The US, in particular, records a high adoption rate of osteonecrosis treatments.

What are the driving factors for the osteonecrosis treatment market across the globe?

The rising cases of orthopedic injuries and increasing geriatric population drive osteonecrosis treatment market growth.

Who are the key players in the osteonecrosis treatment market?

The osteonecrosis treatment market majorly consists of the players such include Novartis AG; Teva Pharmaceutical Industries Ltd.; Zimmer Biomet; Pfizer Inc.; Stryker; Exactech, Inc.; Merck & Co. Inc.; Dr. Reddy’s Laboratories Ltd.; Viatris Inc; And Horizon Therapeutics Plc.

What is the market CAGR value of osteonecrosis treatment market during forecast period?

The CAGR value of the osteonecrosis treatment market during the forecasted period of 2020-2030 is 6.08%

Which type of treatment held the largest share in the osteonecrosis treatment market?

The drugs segment dominated the global osteonecrosis treatment market and held the largest market share of 75.45% in 2022.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Osteonecrosis Treatment Market

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Zimmer Biomet
  • Pfizer Inc.
  • Stryker
  • Exactech, Inc.
  • Merck & Co. Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Viatris Inc
  • Horizon Therapeutics plc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.